Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B London

Showing results (201-210 of 310) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force reportTom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
The New England Journal of Medicine|November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastomaEdward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Journal of the American Academy of Dermatology|July 21, 2020
Characteristics of nonmelanoma skin cancer in children without identifiable risk factorsConnie S Zhong, Carrie C Coughlin, Elena B Hawryluk, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 11, 2014
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupRisa Teshiba, Shinya Kawano, Larry L Wang, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Pediatric Blood & Cancer|December 19, 2013
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)Elizabeth Fox, Yael P Mosse', Holly M Meany, et al.
Research and Practice in Thrombosis and Haemostasis|April 22, 2026
The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopeniaEmily M Harris, Michele P Lambert, Amanda Grimes, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Pageof 31

Showing results (201-210 of 310) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force reportSusan L Cohn, Andrew D J Pearson, Wendy B London, et al.
Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force reportTom Monclair, Garrett M Brodeur, Peter F Ambros, et al.
The New England Journal of Medicine|November 25, 2005
Chromosome 1p and 11q deletions and outcome in neuroblastomaEdward F Attiyeh, Wendy B London, Yael P Mossé, et al.
Journal of the American Academy of Dermatology|July 21, 2020
Characteristics of nonmelanoma skin cancer in children without identifiable risk factorsConnie S Zhong, Carrie C Coughlin, Elena B Hawryluk, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 11, 2014
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupRisa Teshiba, Shinya Kawano, Larry L Wang, et al.
Clinical Pharmacology and Therapeutics|February 20, 2014
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsN Pinto, E R Gamazon, N Antao, et al.
Pediatric Blood & Cancer|December 19, 2013
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621)Elizabeth Fox, Yael P Mosse', Holly M Meany, et al.
Research and Practice in Thrombosis and Haemostasis|April 22, 2026
The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopeniaEmily M Harris, Michele P Lambert, Amanda Grimes, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Pageof 31